On the flip side, their effects can be more sustainable and holistic improving body composition, energy levels, and health markers without forcing your body into an artificially suppressed appetite long-term
Originally developed to help people with type 2 diabetes (T2D) manage their blood sugar, GLP-1RAs have demonstrated significant weight-loss benefits in people without diabetes, resulting in increased use for weight management
compounded options but includes brand-name medication and medical oversight
These discrepancies could be attributed to variations in data collection methods and reporting formats [190]
Liraglutide: for obesity, not just type 2 diabetes
22,32 In a large-scale real-world cohort study of more than 10,000 patients using a GLP-1 RA, abdominal pain was the most common symptom (57.6%), followed by constipation (30.4%), diarrhea (32.7%), and nausea/vomiting (23.4%)